BioSig appoints Mitch Williams as Chief Investment Officer

LOS ANGELES - BioSig Technologies, Inc. (NASDAQ:BSGM), a company specializing in medical device technology, announced Monday the appointment of Mitch Williams as Chief Investment Officer (CIO) following its acquisition of Streamex Exchange Corporation. Williams, a seasoned executive with over 20 years in capital markets, joins the leadership team with a focus on advancing the company’s initiatives in tokenizing real world assets, particularly in the commodity markets. The announcement comes as BioSig’s stock demonstrates remarkable momentum, with InvestingPro data showing a 94% surge in the past week and a 211% return over the last year. The company currently maintains a market capitalization of $104.27 million.

Williams’ extensive experience includes a significant tenure at Wafra Inc., where he achieved a threefold increase in assets under management and consistently delivered top-quartile performance. As a former top-ranked equity analyst at OppenheimerFunds, he led the firm’s flagship fund, further establishing his reputation for high-return investment strategies. According to InvestingPro analysis, BioSig maintains a healthy liquidity position with a current ratio of 2.37, indicating strong ability to meet short-term obligations.

In his new role as CIO, Williams will spearhead strategic positioning within the global commodity market valued at approximately $142.85 trillion. His efforts will center on unlocking new value through the tokenization of commodities, creating secure and scalable solutions for real world asset tokenization.

Henry McPhie, CEO of the combined company, expressed confidence in Williams’ ability to generate new opportunities for shareholders, citing his disciplined investment approach and collaborative leadership style as assets that align well with the company’s culture and growth objectives.

Streamex, now a wholly owned subsidiary of BioSig, has developed infrastructure for primary issuance and exchange that aims to revolutionize commodity finance. The company’s leadership believes that the future of finance lies in tokenization, innovative investment strategies, and decentralized markets.

The press release also contained forward-looking statements regarding the anticipated benefits of the acquisition of Streamex and the company’s ability to maintain Nasdaq listing criteria. These statements are subject to various risks and uncertainties, and actual results could differ materially from those projected. InvestingPro subscribers have access to 15 additional key insights about BioSig, including detailed financial health metrics, valuation analysis, and growth prospects. Unlock comprehensive investment intelligence with an InvestingPro subscription.

The announcement is based on a press release statement issued by BioSig Technologies, Inc.

In other recent news, BioSig Technologies, Inc. announced its intent to merge with Streamex Exchange Corporation in an all-stock transaction designed to take Streamex public on the Nasdaq. This strategic move aims to integrate Streamex’s blockchain-based commodity finance platform with BioSig’s operations, potentially enhancing market reach and capabilities. Additionally, BioSig has recently regained compliance with Nasdaq’s minimum bid price requirement, as its stock maintained a closing bid price of at least $1.00 for ten consecutive business days. On another front, BioSig has changed its independent registered public accounting firm, appointing CBIZ CPAs P.C. after Marcum LLP resigned. This transition follows CBIZ’s acquisition of Marcum’s attest business. Furthermore, BioSig disclosed that its recent capital-raising efforts may have lifted its stockholders’ equity to meet Nasdaq’s requirements, although formal confirmation is still pending. Despite previous challenges, BioSig’s business operations remain unaffected, and the company is actively working to align with Nasdaq’s standards.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.